Capitalizing on the Pea Protein Surge
August 2015
--- Pea protein and inulin supplier Cosucra has set itself an ambitious growth target to its double turnover from €80 million today to €150 million in 2020, as the company looks to ride the protein wave with its pea protein isolate products (Pisane). Jacques Crahay, CEO of Cosucra, discusses the company’s latest plant investment and opportunities on the global protein market.
DOWNLOAD ARTICLE : Capitalizing on the Pea Protein Surge
